Primary |
Depression |
22.2% |
Panic Attack |
22.2% |
Analgesia |
11.1% |
Cerebral Ischaemia |
5.6% |
Endometriosis |
5.6% |
Gastrointestinal Disorder |
5.6% |
Herpes Simplex |
5.6% |
Hypertension |
5.6% |
Major Depression |
5.6% |
Postpartum Depression |
5.6% |
Sleep Disorder |
5.6% |
|
Hyponatraemia |
22.2% |
Convulsion |
11.1% |
Sexual Dysfunction |
11.1% |
Suicide Attempt |
11.1% |
Syncope |
11.1% |
Tremor |
11.1% |
Upper Gastrointestinal Haemorrhage |
11.1% |
Vertigo Positional |
11.1% |
|
Secondary |
Product Used For Unknown Indication |
32.5% |
Depression |
20.0% |
Drug Use For Unknown Indication |
16.1% |
Anxiety |
4.8% |
Intentional Overdose |
4.0% |
Pain |
3.3% |
Schizoaffective Disorder |
2.4% |
Hypertension |
2.4% |
Parkinson's Disease |
1.9% |
Mental Disorder |
1.8% |
Osteoarthritis |
1.8% |
Schizophrenia |
1.5% |
Panic Disorder |
1.2% |
Breast Cancer |
1.2% |
Insomnia |
1.0% |
Thrombosis Prophylaxis |
1.0% |
Drug Exposure During Pregnancy |
0.9% |
Ill-defined Disorder |
0.7% |
Rheumatoid Arthritis |
0.7% |
Bipolar Disorder |
0.7% |
|
Intentional Overdose |
18.8% |
Sopor |
8.1% |
Vomiting |
8.1% |
Tachycardia |
6.5% |
Drug Exposure During Pregnancy |
5.4% |
Suicide Attempt |
5.4% |
Cerebral Haemorrhage |
4.3% |
Overdose |
4.3% |
Rhabdomyolysis |
4.3% |
Suicidal Ideation |
3.8% |
Torsade De Pointes |
3.8% |
Urinary Retention |
3.8% |
Withdrawal Syndrome |
3.8% |
Ecchymosis |
3.2% |
Somnolence |
3.2% |
Abortion Spontaneous |
2.7% |
Disturbance In Attention |
2.7% |
Electrocardiogram Qt Prolonged |
2.7% |
Intra-uterine Death |
2.7% |
Pregnancy |
2.7% |
|
Concomitant |
Product Used For Unknown Indication |
32.4% |
Depression |
14.1% |
Drug Use For Unknown Indication |
8.3% |
Hypertension |
6.3% |
Pain |
6.0% |
Anxiety |
4.0% |
Crohn's Disease |
3.6% |
Rheumatoid Arthritis |
3.6% |
Prophylaxis |
2.4% |
Insomnia |
2.2% |
Multiple Sclerosis |
2.0% |
Parkinson's Disease |
2.0% |
Prostate Cancer |
1.8% |
Osteoporosis |
1.8% |
Breast Cancer |
1.7% |
Diabetes Mellitus |
1.7% |
Schizophrenia |
1.7% |
Nausea |
1.6% |
Constipation |
1.5% |
Hepatitis C |
1.4% |
|
Weight Increased |
16.3% |
Vomiting |
9.7% |
Suicidal Ideation |
7.4% |
Weight Decreased |
6.4% |
Pulmonary Embolism |
5.4% |
Urinary Tract Infection |
5.2% |
Syncope |
5.0% |
Tremor |
5.0% |
Visual Impairment |
5.0% |
Myocardial Infarction |
4.2% |
Suicide Attempt |
4.2% |
Withdrawal Syndrome |
3.7% |
Neutropenia |
3.5% |
Tachycardia |
3.2% |
Death |
3.0% |
Hepatic Encephalopathy |
2.7% |
Pneumonia |
2.7% |
Overdose |
2.5% |
Swelling Face |
2.5% |
Thrombosis |
2.5% |
|
Interacting |
Depression |
26.9% |
Product Used For Unknown Indication |
19.2% |
Drug Use For Unknown Indication |
14.3% |
Urinary Tract Infection |
4.4% |
Anxiety |
3.3% |
Anxiety Disorder |
3.3% |
Bipolar Disorder |
2.7% |
Schizophrenia |
2.7% |
Anorexia Nervosa |
2.2% |
Back Pain |
2.2% |
Essential Hypertension |
2.2% |
Hallucination |
2.2% |
Migraine |
2.2% |
Renal Transplant |
2.2% |
Smoking Cessation Therapy |
2.2% |
Hypertension |
1.6% |
Insomnia |
1.6% |
Myocardial Ischaemia |
1.6% |
Schizoaffective Disorder Depressive Type |
1.6% |
Blood Pressure Increased |
1.1% |
|
Hyponatraemia |
17.6% |
Drug Interaction |
7.8% |
Supraventricular Extrasystoles |
7.8% |
Vomiting |
7.8% |
Psychotic Disorder |
5.9% |
Tremor |
5.9% |
Dyskinesia |
3.9% |
Extrapyramidal Disorder |
3.9% |
Lipodystrophy Acquired |
3.9% |
Liver Disorder |
3.9% |
Malaise |
3.9% |
Metabolic Syndrome |
3.9% |
Somnolence |
3.9% |
Suicidal Ideation |
3.9% |
Transaminases Increased |
3.9% |
Urinary Tract Infection |
3.9% |
Gait Disturbance |
2.0% |
Generalised Oedema |
2.0% |
Grand Mal Convulsion |
2.0% |
Hallucination, Visual |
2.0% |
|